Production (Stage)
HCA Healthcare, Inc.
HCA
$376.59
-$0.05-0.01%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.19% | -10.52% | 17.70% | 22.46% | 16.73% |
| Total Depreciation and Amortization | 8.18% | 8.49% | 9.49% | 7.34% | 5.16% |
| Total Amortization of Deferred Charges | 22.22% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 41.89% | 36.97% | -24.65% | -12.90% | -15.76% |
| Change in Net Operating Assets | -218.30% | -86.73% | 319.33% | -152.03% | 49.14% |
| Cash from Operations | -33.13% | -4.30% | 41.79% | -20.36% | 36.94% |
| Capital Expenditure | 11.36% | -10.87% | -3.84% | -3.22% | 6.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -136.46% | 88.14% | 40.76% | -288.89% | 16.52% |
| Divestitures | -48.06% | 60.00% | -90.91% | -85.71% | 87.88% |
| Other Investing Activities | 2,400.00% | 62.77% | -263.16% | -21.43% | 125.00% |
| Cash from Investing | -14.29% | 15.72% | -3.05% | -5.97% | 21.55% |
| Total Debt Issued | 21.64% | -100.00% | 150,500.00% | -100.00% | 261.53% |
| Total Debt Repaid | 1.29% | -135.16% | -375.07% | 134.09% | -617.45% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -112.37% | -86.81% | -57.46% | -49.40% | -39.48% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 2.70% | -3.13% | -4.32% | -4.27% | -5.71% |
| Other Financing Activities | 5.41% | -50.97% | -36.69% | -1.51% | 1.52% |
| Cash from Financing | -22.94% | -108.18% | 90.28% | 8.76% | -67.72% |
| Foreign Exchange rate Adjustments | 400.00% | -183.33% | 166.67% | -- | -114.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -350.14% | -2,270.45% | 6,993.10% | -2,365.00% | 628.79% |